What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.01%
Annual Rate
CNY 0.01Paid annual
Payout Ratio
190.0%High
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
10.43BCNY
1.55B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
385.57MCNY
57.26M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-24.67%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.6220x
vs all stocks
Updated Aug 20, 2026
52-Week Change
110.58%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
10.43BCNY
1.55B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
10.37BCNY
1.54B · vs all stocks (USD)
Updated Aug 20, 2026
Price to Sales (TTM)
27.05x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Book (MRQ)
5.32x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
26.88x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
-194.27x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Margin
27.80%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.69%.Updated Aug 20, 2026
Profit Margin
-24.67%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
-13.29%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
-2.47%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
-4.80%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
385.57MCNY
57.26M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
2.27CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-13.20%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
91.35MCNY
13.57M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
-53.35MCNY
-7.92M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-95.10MCNY
-14.12M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-66.54%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
24.50MCNY
3.64M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-83.65MCNY
-12.42M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.0050CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
0.01%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
190.00%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -0.96%.Updated Aug 20, 2026
Minority Interest (Equity)
23.60MCNYFY2025 · Dec 31, 2025
Revenue
398.97MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
299.85MCNYFY2025 · Dec 31, 2025
Gross Profit
99.12MCNYFY2025 · Dec 31, 2025
Operating Income
-43.94MCNY
-6.53M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-96.81MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.41MCNYFY2025 · Dec 31, 2025
Net Income
-89.39MCNYFY2025 · Dec 31, 2025
EBIT
-93.12MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-11.20MCNYFY2025 · Dec 31, 2025
Research & Development
46.38MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
37.42MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.95MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
12.14MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.68MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.4800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
184.93MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
184.93MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-89.39MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
628.10KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-24.58MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-28.25MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
169.91MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-89.39MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
4.59MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
121.28MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-61.05MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-3.66MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-808.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
782.68MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-11.87MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-40.85MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
45.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-103.77MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.51MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-44.64KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-65.33MCNYFY2025 · Dec 31, 2025
Shares Outstanding
184.62MSharesUpdated Aug 20, 2026
Float Shares
120.38MSharesUpdated Aug 20, 2026
% Held by Insiders
32.24%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
6.30%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
156.64MCNY
23.26M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
0.8480CNYUpdated Aug 20, 2026
Total Debt (MRQ)
69.06MCNY
10.26M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0348x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
4.92x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
10.62CNYUpdated Aug 20, 2026
Total Assets
2.42BCNY
359.56M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.47BCNYFY2025 · Dec 31, 2025
Total Liabilities
427.85MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
946.27MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
89.90MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
337.94MCNYFY2025 · Dec 31, 2025
Cash
169.91MCNYFY2025 · Dec 31, 2025
Cash Equivalents
35.61MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
205.52MCNYFY2025 · Dec 31, 2025
Accounts Receivable
399.42MCNYFY2025 · Dec 31, 2025
Inventory
241.19MCNYFY2025 · Dec 31, 2025
Accounts Payable
227.43MCNYFY2025 · Dec 31, 2025
Short-term Debt
19.91MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
5.28MCNYFY2025 · Dec 31, 2025
Long-term Debt
49.15MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
13.27MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
184.62MCNYFY2025 · Dec 31, 2025
Retained Earnings
557.50MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.99BCNY
296.02M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.00CNYUpdated Aug 20, 2026
52-Week High
58.80CNYUpdated Aug 20, 2026
52-Week Change
110.58%
vs all stocks
Updated Aug 20, 2026
Beta
0.6220x
vs all stocks
Updated Aug 20, 2026
50-Day MA
22.21CNYUpdated Aug 20, 2026
200-Day MA
23.57CNYUpdated Aug 20, 2026
Avg 10-Day Volume
17.49MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
8.45MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.5200CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant